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Open access under the ElThe 18 kDa translocator protein (TSPO) also known as the peripheral benzodiazepine receptor (PBR),
mediates the transportation of cholesterol and anions from the outer to the inner mitochondrial mem-
brane in different cells types. Although recent evidences indicate a potential role for TSPO in the develop-
ment of inﬂammatory processes, the mechanisms involved have not been elucidated. The present study
investigated the ability of the speciﬁc TSPO ligands, the isoquinoline carboxamide PK11195 and benzodi-
azepine Ro5-4864, on neutrophil recruitment promoted by the N-formylmethionyl-leucyl-phenylalanine
peptide (fMLP), an agonist of G-protein coupled receptor (GPCR). Pre-treatment with Ro5-4864 abrograted
fMLP-induced leukocyte-endothelial interactions in mesenteric postcapillary venules in vivo. Moreover,
in vitro Ro5-4864 treatment prevented fMLP-induced: (i) L-selectin shedding and overexpression of
PECAM-1 on the neutrophil cell surface; (ii) neutrophil chemotaxis and (iii) enhancement of intracellular
calcium cations (iCa+2). Intriguingly, the two latter effects were augmented by cell treatment with
PK11195. An allosteric agonist/antagonist relation may be suggested, as the effects of Ro5-4864 on
fMLP-stimulated neutrophils were reverted by simultaneous treatment with PK11195. Taken together,
these data highlight TSPO as a modulator of pathways of neutrophil adhesion and locomotion induced
by GPCR, connecting TSPO actions and the onset of an innate inﬂammatory response.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
TSPO (18 kDa), previously knownas PBR, is a ﬁve transmembrane
domain protein expressed mainly in steroid-synthesizing tissues,
such as adrenal and brain [1,2], as well as and in the lungs, kidneys,
liver [2], peripheral nervous system and immune cells [3]. TSPO is
mainly localized at contact sites between inner and outermitochon-
drial membranes as a part of the MPTP [4,1], and in the Golgi appa-
ratus, lysosomes, peroxisomes and on the plasma membrane [5,6].
Cholesterol, porphyrins and endozepines are TSPO endogenous
ligands, whilst synthetic compounds that activates TSPO arein; CD62L, L-selectin; fMLP,
-protein coupled receptor;
ermeability transition pore;
-1, platelet-endothelial cell
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sevier OA license.primarily benzodiazepines and isoquinolines carboxamides; thus,
diazepam and Ro5-4864 are classiﬁed as benzodiazepines and
PK11195 is the most employed isoquinoline compound [7,8]. TSPO
activation mediates the translocation of cholesterol from the outer
to the innermitochondrialmembrane [7],mitochondrial respiration
and cell proliferation and apoptosis [9,10]. There is some evidence
that TSPO activation could modulate innate immune response,
including those affecting peripheral organs and the central nervous
system [11–14]. Themodulatory action of TSPO on inﬂammation in-
volves events at the cellular and vascular levels, which result in
reduction of carrageenan-induced paw edema [15,16], apoptosis
of lymphocytes [17] and neutrophil migration in diazepam treated
rats [18–20].
Neutrophil inﬂux into the inﬂammation focus is a hallmark of
innate inﬂammation. Endogenous and exogenous inﬂammatory
agents bind to membrane or intracellular receptors of circulating
neutrophils, or act directly on intracellular pathways activating
biochemical pathways that stimulate metabolic and morphological
modiﬁcations required for cell focal adhesion and motility [21].
Neutrophil interaction with microcirculatory vessel endothelial
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in both cell types [21,22]. L-selectin expressed on leukocytes and P
and E-selectin expressed on endothelial cells bind their ligands on
the opposing cells leading to the tethering and rolling behaviors
[23]. Successively, metalloprotease enzymes facilitate L-selectin
shedding from the neutrophil membrane, providing an outside-in
signal for the cell to ﬁrm adhesion [22]. Integrin molecules mediate
adhesion by interacting with cell surface components and immu-
noglobulin superfamily molecules on the endothelium [21,22].
Afterward, neutrophils crawl into the adjacent tissue via hetero-
philic and homophilic interactions with the immunoglobulins
superfamily molecules, such PECAM-1 [24]. Finally, chemotactic
chemical mediators in the extravascular matrix bind to neutrophil
membrane receptors and trigger the intracellular signals responsi-
ble for direct cell locomotion to the lesion [25].
To date, the role of TSPO activation in the trafﬁcking of neutro-
phil during acute inﬂammation is unknown. Here, we show that
two structurally-unrelated TSPO ligands modulate neutrophil–
endothelial interactions and chemotaxis promoted by a classical
GPCR agonist, with the indication that an effect upon iCa+2 mobili-
zation may be involved on the evident modulation of neutrophil
locomotion.2. Materials and methods
2.1. Reagents
Ro5-4864, PK11195, RPMI medium, bovine serum albumin
(BSA), paraformaldehyde (PAF), N-formylmethionyl-leucyl-phen-
ylalanine (fMLP), ﬂuo-3 AM, saponin and oyster glycogen were
purchased from Sigma Chemical Co. (St. Louis, MO, USA). Ethanol
was purchased from Labsynth (São Paulo, SP, Brasil). L-selectin
monoclonal antibody conjugated to PE (anti-rat CD62L), b2-inte-
grin monoclonal antibody conjugated to FITC (anti-rat CD18), and
PECAM-1 monoclonal antibody conjugated to PE (anti-rat CD31)
were purchased from Pharmigen – BD Biosciences (San Jose, CA,
USA). Anti-TSPO polyclonal antibody and FITC-conjugated donkey
anti-goat IgG were purchased from Abcam (Cambridge, MA, USA).
2.2. Animals
Male Wistar rats weighting 230–250 g were used. The animals
were housed in plastic cages, in temperature-controlled (21–
23 C) and artiﬁcially lighted rooms on a 12 h light/12 h dark cycle,
with free access to rodent chow and water. All procedures were
performed according to protocols approved by the Brazilian Soci-
ety of Science of Laboratory Animals (SBCAL) for proper care and
use of experimental animals.
2.3. Intravital microscopy
Rats were anesthetized by i.p. injection of ketamine:xilazine
(0.2 g/kg:0.02 g/kg) and the mesentery was surgically exteriorized.
Animals were maintained on a special board thermostatically con-
trolled at 37 C, which included a transparent platform on which
the tissue to be transilluminated was placed. The preparation was
kept moist and warmed by irrigating the tissue with a warmed
(37 C) Ringer-Locke solution (pH 7.2–7.4). The rate of solution out-
ﬂow onto the exposed tissue was controlled to keep the preparation
in continuous contact with a ﬁlm of the solution. Transilluminated
images were obtained by optical microscopy, captured with a video
camera and simultaneously transmitted to a computer.
Interaction between leukocytes and vessel walls were analyzed
by determining the number of rolling and adherent leukocytes on
the postcapillary venule wall (20–30 lm diameter, 200 lm length)of the mesentery. Leukocytes moving in the periphery of the axial
stream, in contact with the endothelium, were considered to be
rollers and their number was determined in 5 min periods. The
number of leukocytes adhered to the endothelium (stopped at
the vessel wall) was determined in the same vascular segment at
the end of 5 min. The number of rolling and adhered cells was
quantiﬁed after topical application of RPMI, Ethanol 0.001%,
PK11195 (100 nM) or Ro5-4864 (100 nM) in basal condition or
after inducing a local inﬂammatory response by the topical appli-
cation of 10 ll fMLP (108 M). Three ﬁelds were evaluated per ani-
mal after application. Data were then averaged for each animal.
2.4. L-selectin, b-integrin and PECAM-1 expressions
Blood was collected from abdominal aorta and after erythro-
cytes lysis, 1  106 leukocytes were incubated with RPMI, ethanol
0.001% (vehicle), PK11195 (100 nM)and/or Ro5-4864 (100 nM) for
1 hour (37 C, 5% CO2). Cells were washed, recovered with PBS and
incubated with or without fMLP (108 M) for 1hour (37 C, 5% CO2).
After being washed, cells were incubated with anti-CD62L, anti-
CD18 and anti-CD31 for 20 min at 4 C in the dark and analyzed
by ﬂow cytometry (FACSCaliburR, Becton Dickinson Immunocy-
tometry Systems, San Jose, CA, USA). Data from 100.000 events
was acquired and analyzed with FlowJo (Treestar – version 7.2.1,
Ashland, OR, USA).
2.5. TSPO ligand expression
Leukocytes were prepared as described above. After being
washed, cells were ﬁxed with 4% paraformaldehyde and permeabi-
lized with 0.5% Saponin. Then, cells were incubated with 3% BSA
for 30 minutes to block unspeciﬁc binding of the antibodies. After
washing, cells were incubated for 60 min at room temperature with
anti-TSPO polyclonal antibody, washed, incubated for 60 min at
room temperature with FITC-conjugated donkey anti-goat IgG and
analyzed by ﬂow cytometry.
2.6. In vitro chemotaxis
Peritoneal neutrophils were obtained 4 h after i.p. injection of
10 mL of 1% oyster glycogen solution in sterile PBS. Cells were col-
lected and incubated with ethanol 0.001%, PK11195 (100 nM) and/
or Ro5-4864 (100 nM) for 1 h (37 C, 5% CO2). After washing, cells
were resuspended at a concentration of 6  106 cells/mL in RPMI
containing 0.1% BSA and 25 lL was loaded on the top well of a
commercially available Neuroprobe ChemoTx-101-3™ 96-well
plate equipped with a 3 lm pore size ﬁlter (Neuroprobe, Leaming-
ton Spa, UK). As chemoattractant, 30 lL of fMLP 108 M was added
in the bottom well and incubated for 2 h (37 C, 5% CO2). Migrated
neutrophils were counted after a dilution in Turk’s solution, using a
Neubauer haematocymometer.
2.7. iCa+2 measurement by confocal microscopy
Peritoneal neutrophils were obtained as described above. Cells
were collected by rising the abdominal cavity with 40 mL of sterile
Krebs–HEPES buffer (pH 7.3). The iCa+2 level was analyzed using a
laser scanning confocal microscope with excitation and emission
wavelengths of 488/515 nm, respectively. Isolated neutrophils
were incubated with 10 lM Fluo-3 AM for 45 min at room temper-
ature. Neutrophils were washed and suspended at 4  106 cells/mL
in Krebs–HEPES buffer. For each experiment 90 lL of cell suspen-
sion was added to glass-bottomed culture dishes and allowed to
settle. The cells were imaged with an inverted confocal microscope
using a 63 objective. The ﬁrst images were acquired and ethanol
(0.001%), PK11195, Ro5-4864 or PK11195 + Ro5-4864 was added
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and a new acquisition of the images was done. Values for 10–15
cells per experimental group were obtained and the means ± s.e.m.
of the ﬂuorescence intensity of these cells was then calculated.
2.8. Statistical analysis
Means and s.e.m. of all data are presented and were compared
by Student’s t-test or ANOVA. Turkey’s Multiple Comparisons test
was performed for determining the signiﬁcance of the differences
between experimental conditions. GraphPad Prism 4.0 software
(San Diego, CA, USA) was employed. Values of p 6 0.05 were con-
sidered signiﬁcant.3. Results
3.1. fMLP-induced leukocyte-endothelial interactions were only
affected by Ro5-4864 treatment
In the initial steps of an inﬂammation reaction, the numbers of
rolling cells decrease due to the concomitant enhancement of ad-
hered cells in the microvessels close to the injured area [26,27].
These phenomena can be easily observed by intravital microscopy
assay after topical application of phlogistic agents, such as fMLP,
into the microcirculatory networks. Here, topical application of
fMLP on the mesenteric microcirculation of animals pre-treated
with RPMI or vehicle reduced the number of rolling and enhanced
the number of adhered cells. PK11195 pre-treatment had no addi-
tional effect on fMLP action, while Ro5-4864 abolished the fMLP
response (Fig. 1A and B).
3.2. Only Ro5-4864 blocked fMLP-induced L-selectin cleavage and
PECAM-1 enhancement
Changes in the expression of adhesion molecules in leukocyte
membrane, rather than in endothelial cells, are responsible for
reduction in rolling and enhancement of adhesion in the microvas-
culature of the inﬂamed area [23,27]. Then, based on results ob-
tained in intravital microscopy study, the effects of TSPO ligands
on neutrophil adhesion molecules expressions were established.
Data obtained showed that Ro5-4864 pre-incubation inhibited
both fMLP-induced L-selectin cleavage and enhancement of
PECAM-1 expression on the cell membrane (Fig. 2A and B). Inter-
estingly, TSPO ligand modulation was selective as they did notFig. 1. Rolling (A) and adherent (B) leukocytes in the mesentery postcapillary venules of
Ro5-4864 (100 nM). fMLP (108 M) or PBS were topically applied. Data were obtained ea
as the means ± s.e.m. of three animals in each group. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001 vaffect b2-integrin expression. Neither Ro5-4864 nor PK11195
altered b2-integrin expression on neutrophil surface in the pres-
ence or absence of fMLP stimulation (Fig. 2C).
Although extensive structure–activity relationship studies has
been performed to hypothesize various TSPO pharmacophore mod-
els, the understanding about the molecular structure of TSPO and
the characterization of multiple TSPO binding sites is limited [14].
In order to investigate the relation of TSPO ligands on the effects
observed in the present study, neutrophils were then incubated,
simultaneously, with both TSPO ligands. Data obtained suggest that
Ro5-4864 and PK11195maintained an allosteric agonist/antagonist
relationship in the modulation of neutrophil functions, as co-treat-
mentswith PK11195 and Ro5-4864 abrogated the Ro5-4864 actions
on fMLP-induced L-selectin shedding (Fig. 2D) and PECAM-1
expression (Fig. 2E).
It is noteworthy that TSPO expression on circulating neutrophils
is higher than expression detected in other cell type, such as lym-
phocytes, and that fMLP stimulation increased the concentration of
neutrophil intracellular TSPO (Table 1).
3.3. fMLP-induced neutrophil chemotaxis is inhibited byRo5-4864 and
enhanced by PK11195
Despite observation on effects of TSPO ligands on neutrophil-
endothelial interactions, when chemotaxis was measured we \ob-
served that both agents could evoke opposite effects. Data presented
in Fig. 3 show that fMLP increased neutrophil chemotaxis, which
was abrogated in cells pre-treated with Ro5-4864. Conversely,
pre-treatment with PK11195 markedly increased fMLP-induced
neutrophil chemotaxis. Co-treatments with PK11195 and Ro5-
4864 reversed the inhibitory effect of Ro5-4864.
3.4. Ro5-4864 treatment blockaded and PK11195 enhanced the
iCa+2concentration in fMLP-stimulated neutrophils
It iswell established that fMLP stimulationprovokes transient in-
crease in iCa+2, dependingonamobilization fromintracellular stores
and subsequent inﬂux across the plasmamembrane,which is essen-
tial to neutrophil chemotaxis [28]. Images of confocal microscopy
assay conﬁrmed the rapid augmentation of iCa+2 concentrations
after fMLP stimulation, which was abrogated in cells pre-treated
with Ro5-4864. Differently, pre-treatment with PK11195 markedly
increased the iCa+2 concentration and co-treatment with PK11195
and Ro5-4864 normalized the iCa+2 levels after fMLP stimulation
(Fig. 4). Table 2 shows maximum effect after fMLP stimulation.rats locally treated with RPMI, TSPO-vehicle (ethanol 0.001%), PK11195 (100 nM) or
ch 5 min intervals, ten minutes after fMLP or PBS applications. Values are expressed
s. respective PBS.
Fig. 2. L-selectin (A and D), PECAM-1 (B and E) and b2-integrin expression on neutrophils pre-treated with RPMI, TSPO-vehicle (ethanol 0.001%), PK11195 (100 nM) and/or
Ro5-4864 (100 nM) and incubated with PBS or fMLP (108 M) one hour later. Values are expressed as the means ± s.e.m. of neutrophils collected from 5 to 8 animals.
⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001 vs. respective PBS.
Table 1
TSPO density on peripheral blood leukocytes.
Neutrophils Lymphocytes
Basal 26.10 ± 1.27 12.78 ± 0.95**
fMLP (108 M) 33.25 ± 0.43* 10.26 ± 1.02
Values are expressed as mean ± s.e.m. analyses conducted with cells collected from
four animals.
* P < 0.01.
** P < 0.001 vs. basal neutrophils.
Fig. 3. Chemotaxis of neutrophils pre-treated with RPMI, TSPO-vehicle (ethanol
0.001%), PK11195 (100 nM) and/or Ro5-4864 (100 nM) and stimulated with fMLP
(108 M) for two hours. Values are expressed as the means ± s.e.m. of neutrophils
collected from 4 to 5 animals. ⁄⁄P < 0.01 vs. TSPO-vehicle;  basal values.
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It is noteworthy that TSPO has been proposed as a sensitive
biomarker for neuro and lung inﬂammation, and for neurodegener-
ation diseases [12–14]. Data here obtained further extended the rel-
evance of TSPO on inﬂammation by showing, for the ﬁrst time, that
benzodiazepine TSPO activation negatively modulates circulatingcell behavior in the inﬂamedmesentery, by affectingGPCR activated
pathways.
The speciﬁc action of the benzodiazepine ligand on leukocyte-
endothelial interaction was visualized by abrogating the reduced
and enhanced number of rolling and adhesion of leukocytes after
fMLP stimulation, respectively, and by affecting the expressions
of constitutive neutrophils adhesion molecule, L-selectin and
PECAM-1. Both molecules are rapidly activated during the process
of cell activation, cleaved or re-internalized, resulting in transient
expressions [27,29]. Therefore, altering the transient membrane
expression of both molecules will result in a reduction of neutro-
phil-endothelial interactions. Interestingly, TSPO ligandmodulation
wasselectiveas ligandsdidnot affectb2-integrinsexpression,which
cell surface density depends on their translocation from cytosol
granule [25]. Therefore, it may be supposed that Ro5-4864 might
produce limited and speciﬁc responses once applied to neutrophils
and that it may affect activation, shedding or re-circulation of neu-
trophil constitutive molecules.
Different from observed in leukocyte–endothelial interactions,
the benzodiazepine and the isoquinolines carboxamide agent
displayed opposite effect on fMLP-induced neutrophil direct loco-
motion. While the Ro5-4864 inhibited the process, according to
the negative modulation actions on neutrophil–endothelial inter-
actions, the PK11195 marked enhanced the direct cell movement.
Chemotaxis is a process that requires focal adhesion sites, actin
cytoskeletal polarization and microtubule reorganization to cell
movement and orientation in response to chemotactic agents. The
perfect pool of membrane receptors and their rearrangement on
the cell surface during the migration is a crucial point [30]. In this
context, the functional activity of b2-integrin and PECAM-1 on
neutrophil motility and direction has been proposed. The role of
b2-integrin is controversial, but strong evidences supports that
PECAM-1 favors the F-actin polymerization during cell movement
[31–33]. Based on inhibitory actions of Ro5-4864 on GPCR-induced
adhesion molecules expressions and chemotaxis, it may suppose a
connection of PECAM-1 expression and chemotaxis after TSPO acti-
vation by the benzodiazepine ligand. Differently, our data indicate
that this hypothesis cannot be suggested to the PK11195. Together,
data corroborate that TSPO activations by benzodiazepine and
Fig. 4. Intracellular calcium mobilization in neutrophils pre-treated with TSPO-vehicle (ethanol 0.001%), PK11195 (100 nM) and/or Ro5-4864 (100 nM) and stimulated or not
with fMLP (108 M). Images were obtained by confocal microscopy (B). Values are expressed as the means of neutrophils collected from three animals.
Table 2
Maximum effect of intracellular calcium mobilization after fMLP (108 M)
stimulation.
TSPO-
vehicle
Ro5-4864 PK11195 Ro5-
4864 + PK11195
Maximum
effect (%)
100 ± 0 2.54 ± 2.50* 248.7 ± 38.71* 110.6 ± 45.35
Values are expressed as mean ± s.e.m. of animals.
* P < 0.01 vs. TSPO-vehicle.
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pathways on GPCR-induced neutrophil migration.
fMLP is a chemoattractant that binds to seven domain trans-
membrane receptor coupled to the Gi family of G proteins. After
binding to agonists, receptors activate the heterotrimeric G protein,
which dissociates into a and bc subunits, activating phospholipase
C (PLC). PLC hydrolyses phosphatidylinositol 4,5-biphosphate (PIP2)
generating inositol-tri-phosphate (IP3), which releases calcium
from endoplasmic reticulum stores, and diacylglycerol (DAG),
resulting in activation of protein kinase C (PKC) isoforms. Cytosolic
calcium levels enhancement is a necessary condition for neutrophil
response to formyl peptides and it occurs by an initial transient
release from intracellular storage sites followed by a more delayed
inﬂux across the plasma membrane [28,34].
Previous studies have reported an association between TSPO
ligation and iCa+2 mobilization in resting cells, but results are
controversial. Triakontatetraneuropeptide (TTN) and eiksoneuro-
peptide (ENP), both natural diazepam-binding inhibitor (DBI)-de-
rived peptides, induced a rapid and transient rise of iCa+2 in
human neutrophils, and only the effect caused by TTN was
depended on enhanced plasmamembrane permeability to extracel-
lular Ca+2 [35]. In addition, Ro5-4864 treatment, but not PK11195,
increased free iCa+2 concentration in resting human neutrophils,
depending on extracellular inﬂux [36]. The Ro5-4864 effect was
antagonized by pre-incubation with PK11195 [36]. Conversely,
PK11195 increased iCa+2 concentration in HT-29 cells [37]. Our
own data that Ro5-4864 and PK11195 affected the iCa+2 in opposite
direction clearly provides a mechanistic explanation to their
intriguing pharmacology.Based on thermodynamic studies of ligand-receptor interaction,
Ro5-4864 and PK11195 have been categorized as TSPO agonist and
antagonist, respectively [38]. However, new data revealed that
according to the cell type and downstream actions evaluated,
and the concentrations of ligand analyzed, Ro5-4864 and
PK11195 may induce similar or opposite effects [39–41]. This dis-
crepancy certainly depends on the dynamic of ligand–receptor
interaction, taking into account also the number of receptors ex-
pressed in different cells. In this context, our study conﬁrmed that
circulating neutrophils express higher amount of TSPO than lym-
phocytes [3], which may confer them as a target to TSPO ligands.
In addition, Ro5-4864 and PK11195 maintained an agonist/antag-
onist relation on the studied effects, as Ro5-4864 and PK11195
co-incubation reversed the effects on adhesion molecules expres-
sion, chemotaxis and calcium mobilization.
Collectively, the data herein presented point out TSPO as an
endogenous modulator of intracellular pathways of GPCR activa-
tion in neutrophils, connecting TSPO actions and the onset of the
immune innate inﬂammatory response. Nevertheless, positive or
negative actions on the process may be triggered by the different
TSPO ligands, which seem to be dependent on activation of speciﬁc
allosteric sites on the neutrophil receptor, which is up-regulated by
GPCR activation.
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